Literature DB >> 24748934

Toll-like receptor expression and signaling in human diabetic wounds.

Mohan R Dasu1, Sandra J Martin1.   

Abstract

AIM: To examine the contribution of toll-like receptors (TLRs) expression and activation to the prolonged inflammation often seen in human diabetic wounds.
METHODS: Debridement wound tissue was collected from diabetic patients with informed consent. Total RNA and protein were isolated and subjected to real-time polymerase chain reaction and Western blot analyses.
RESULTS: TLR1, 2, 4, and 6 mRNA expressions were increased significantly in wounds of diabetic patients compared with non-diabetic wounds (P < 0.05). MyD88 protein expression was significantly increased in diabetic wounds compared to non-diabetic wounds. Interleukin-1beta, tumor necrosis factor-alpha concentration nuclear factor-kappa B activation, and thiobarbituric acid reactive substances were increased in diabetic wounds compared to non-diabetic wounds (P < 0.01).
CONCLUSION: Collectively, our novel findings show that increased TLR expression, signaling, and activation may contribute to the hyper inflammation in the human diabetic wounds.

Entities:  

Keywords:  Inflammation; Interleukin-1β; Toll-like receptors 2; Toll-like receptors 4; Tumor necrosis factor-α; Type 2-diabetes mellitus; Wound healing

Year:  2014        PMID: 24748934      PMCID: PMC3990321          DOI: 10.4239/wjd.v5.i2.219

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


  28 in total

Review 1.  TLR signaling.

Authors:  T Kawai; S Akira
Journal:  Cell Death Differ       Date:  2006-05       Impact factor: 15.828

2.  Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse.

Authors:  Mohammad K Mohammad; Michael Morran; Brandon Slotterbeck; Douglas W Leaman; Yaping Sun; Hermann von Grafenstein; Soon-Cheol Hong; Marcia F McInerney
Journal:  Int Immunol       Date:  2006-05-25       Impact factor: 4.823

3.  Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes.

Authors:  Min Jeong Song; Kang Ho Kim; Jeong Min Yoon; Jae Bum Kim
Journal:  Biochem Biophys Res Commun       Date:  2006-06-06       Impact factor: 3.575

4.  Demonstration of increased toll-like receptor 2 and toll-like receptor 4 expression in monocytes of type 1 diabetes mellitus patients with microvascular complications.

Authors:  Sridevi Devaraj; Ishwarlal Jialal; Jung-Mi Yun; Andrew Bremer
Journal:  Metabolism       Date:  2010-02-12       Impact factor: 8.694

5.  Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes.

Authors:  S J Creely; P G McTernan; C M Kusminski; ff M Fisher; N F Da Silva; M Khanolkar; M Evans; A L Harte; S Kumar
Journal:  Am J Physiol Endocrinol Metab       Date:  2006-11-07       Impact factor: 4.310

6.  Human skin wounds: a major and snowballing threat to public health and the economy.

Authors:  Chandan K Sen; Gayle M Gordillo; Sashwati Roy; Robert Kirsner; Lynn Lambert; Thomas K Hunt; Finn Gottrup; Geoffrey C Gurtner; Michael T Longaker
Journal:  Wound Repair Regen       Date:  2009 Nov-Dec       Impact factor: 3.617

7.  Amelioration in wound healing in diabetic toll-like receptor-4 knockout mice.

Authors:  Mohan R Dasu; Ishwarlal Jialal
Journal:  J Diabetes Complications       Date:  2013-06-15       Impact factor: 2.852

8.  Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat.

Authors:  Jeremy E Davis; Nicholas K Gabler; Jennifer Walker-Daniels; Michael E Spurlock
Journal:  Obesity (Silver Spring)       Date:  2008-04-10       Impact factor: 5.002

Review 9.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

10.  High glucose induces toll-like receptor expression in human monocytes: mechanism of activation.

Authors:  Mohan R Dasu; Sridevi Devaraj; Ling Zhao; Daniel H Hwang; Ishwarlal Jialal
Journal:  Diabetes       Date:  2008-07-23       Impact factor: 9.461

View more
  14 in total

1.  Topical nicotinic receptor activation improves wound bacterial infection outcomes and TLR2-mediated inflammation in diabetic mouse wounds.

Authors:  Mari Kishibe; Tina M Griffin; Melissa Goslawski; James Sinacore; Sascha A Kristian; Katherine A Radek
Journal:  Wound Repair Regen       Date:  2018-10-24       Impact factor: 3.617

Review 2.  Toll-Like Receptor Function in Acute Wounds.

Authors:  Lin Chen; Luisa A DiPietro
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-10-01       Impact factor: 4.730

3.  Resveratrol ameliorates experimental periodontitis in diabetic mice through negative regulation of TLR4 signaling.

Authors:  Lei Zhen; De-sheng Fan; Yan Zhang; Xin-ming Cao; Li-ming Wang
Journal:  Acta Pharmacol Sin       Date:  2014-12-22       Impact factor: 6.150

4.  Ozone improved the wound healing in type 2 diabetics via down-regulation of IL- 8, 10 and induction of FGFR expression.

Authors:  Olga Teplyakova; Yurii Vinnik; Anna Drobushevskaya; Natalia Malinovskaya; Andrey Kirichenko; Darya Ponedelnik
Journal:  Acta Biomed       Date:  2022-05-11

5.  Oestrogen promotes healing in a bacterial LPS model of delayed cutaneous wound repair.

Authors:  Rachel Crompton; Helen Williams; David Ansell; Laura Campbell; Kirsty Holden; Sheena Cruickshank; Matthew J Hardman
Journal:  Lab Invest       Date:  2016-02-08       Impact factor: 5.662

6.  Toll-like receptors-2 and -9 (TLR2 and TLR9) gene polymorphism in patients with type 2 diabetes and diabetic foot.

Authors:  Mohamed-Naguib Abdalla Wifi; Maha Assem; Rasha Hamed Elsherif; Hameda Abdel-Fattah El-Azab; Aasem Saif
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

7.  Toll-Like Receptor 4 (TLR4)/Cyclooxygenase-2 (COX-2) Regulates Prostate Cancer Cell Proliferation, Migration, and Invasion by NF-κB Activation.

Authors:  Wei Wang; Jiye Wang
Journal:  Med Sci Monit       Date:  2018-08-11

8.  The Reduced Expression of EOLA1 May Be Related to Refractory Diabetic Foot Ulcer.

Authors:  Mingxia Wu; Weiling Leng; Hang Pan; Xiaotian Lei; Liu Chen; Xinshou Ouyang; Ziwen Liang
Journal:  Mediators Inflamm       Date:  2019-03-17       Impact factor: 4.711

9.  A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus.

Authors:  Shui-Han Zhang; Yu-Hui Qin; Dan He; Jian-Hua Huang; Zhe-Yu Zhang; Qing Du; Wei-Jun Peng; Rong Yu; Si-Fang Zhang
Journal:  Drug Des Devel Ther       Date:  2019-11-28       Impact factor: 4.162

10.  Insulin treatment prevents wounding associated changes in tissue and circulating neutrophil MMP-9 and NGAL in diabetic rats.

Authors:  Maryam Abdollahi; Taria Shin Yi Ng; Alireza Rezaeizadeh; Sarah Aamidor; Stephen M Twigg; Danqing Min; Susan V McLennan
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.